Bonita David P's Form 4 filing
Windward Bio Group AGWWB · filed Nov 18, 2026
- Accession no.
- 0000947871-26-001039
- Filed
- Nov 18, 2026, 5:12 PM ET
- Trade date
- Nov 16, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market purchases total $20.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bonita David PCIK 0001572451 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Shares | PPurchaseAcquired | +1,176,471 | $17.00 | +$20,000,007 | 1,708,103 | Indirect | Duplicate filing |
| Nov 16, 2026 | Common Shares | CConversionAcquired | +3,561,936 | –F4 | – | 5,270,039 | Indirect | Duplicate filing |
| Nov 16, 2026 | Common Shares | CConversionAcquired | +1,611,008 | –F4 | – | 6,881,047 | Indirect | Duplicate filing |
| Nov 16, 2026 | Common Shares | MOption exerciseAcquired | +216,668 | $0.02F5 | +$4,333.36 | 7,097,715 | Indirect | Duplicate filing |
| Nov 16, 2026 | Common Shares | FTax withholdingDisposed | −232 | $17.00 | −$3,944 | 7,097,483 | Indirect | Duplicate filing |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Shares | CConversionDisposed | −3,561,936 | $0.00 | $0 | 0 | Indirect | Duplicate filing |
| Nov 16, 2026 | Common Shares | CConversionDisposed | −1,611,008 | $0.00 | $0 | 0 | Indirect | Duplicate filing |
| Nov 16, 2026 | Common Shares | MOption exerciseDisposed | −216,668 | $0.00 | $0 | 0 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
Each Series A Preferred Share and Series B Preferred Share automatically converted into the number of Common Shares on a 1-to-1 basis immediately prior to the closing of the Issuer's initial public offering and has no expiration date.
Referenced by the price of 2 transactions in Table I.
- F5
The exercise price is in US Dollars and reflects the conversion of CHF to USD at an exchange rate of $1.2151 to CHF 1.00 as of October 30, 2026, as approved by the Issuer's board of directors.
Referenced by the price of 1 transaction in Table I.